{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:05:58Z","timestamp":1789200358935,"version":"build-2803163510"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Considering the effect of beclomethasone on allergic rhinitis or nasal polyps, it has been attempted to find the best method of using this drug to have the maximum effect and increase the patients' satisfaction. Therefore, the aim of this study was to compare the efficacy of beclomethasone aerosol and aqueous nasal sprays in the patients with nasal polyps.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This double-blind randomized clinical trial was conducted on 60 patients with nasal polyps. The patients were divided into two groups. The first group (beclomethasone dipropionate aqueous [BD-AQ] group) was treated with daily two puffs of beclomethasone aqueous nasal spray 50 \u03bcg in each nostril, and the second group (beclomethasone dipropionate aerosol [BD-A] group) was treated with two puffs of aerosol beclomethasone 50 \u03bcg in each nostril daily for 6 months. At the beginning of the study, the sino-nasal outcome test-22 (SNOT-22) and Lund-Mackay scores were recorded after the evaluation of disease status and the severity of symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The results of this study demonstrated that the mean changes in Lund-Mackay and SNOT-22 scores (83 \u00b1 6.30 and 4.25 \u00b1 31.60, respectively) in the BD-A group were significantly higher than the BD-AQ group (2.01 \u00b1 3.87and 9.83 \u00b1 24.13, respectively) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05), but there was no significant difference in the patients' satisfaction between the two groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>According to the results of this study, patients with nasal polyps showed a significant improvement following both the interventions, but the disease severity in the BD-A group was significantly higher than the BD-AQ group based on the mean values of Lund-Mackay score.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_30_20","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T09:46:01Z","timestamp":1640339161000},"page":"51","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery System in Nasal Polyps"],"prefix":"10.4103","volume":"10","author":[{"given":"Ahmad","family":"Rezaeian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirabbas","family":"Kargoshaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Rastegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-51-20240830","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1710-1492-7-S1-S3","article-title":"Allergic rhinitis","volume":"7","author":"Small","year":"2011","journal-title":"Allergy Asthma Clin Immunol"},{"key":"R2-51-20240830","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.jaci.2009.12.989","article-title":"Rhinitis and sinusitis","volume":"125","author":"Dykewicz","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R3-51-20240830","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R4-51-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino12.000","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists","volume":"50","author":"Fokkens","year":"2012","journal-title":"Rhinology"},{"key":"R5-51-20240830","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/000348941212100904","article-title":"Etiology of nasal polyps in cystic fibrosis: Not a unimodal disease","volume":"121","author":"Steinke","year":"2012","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R6-51-20240830","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/lary.24418","article-title":"Analysis of comorbidities and objective parameters in refractory chronic rhinosinusitis","volume":"123","author":"Batra","year":"2013","journal-title":"Laryngoscope"},{"key":"R7-51-20240830","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.anai.2014.07.025","article-title":"Diagnosis and management of rhinosinusitis: A practice parameter update","volume":"113","author":"Peters","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R8-51-20240830","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jaci.2018.10.037","article-title":"New delivery forms of nasal corticosteroids","volume":"143","author":"Fokkens","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"R9-51-20240830","first-page":"CD011996","article-title":"Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis","volume":"4","author":"Chong","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R10-51-20240830","first-page":"CD006549","article-title":"Topical steroids for nasal polyps","volume":"12","author":"Kalish","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R11-51-20240830","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11882-017-0720-3","article-title":"Update on Intranasal Medications in Rhinosinusitis","volume":"17","author":"Snidvongs","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"R13-51-20240830","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4193\/Rhino10.268","article-title":"Nasally inhaled pulsating aerosols: Lung, sinus and nose deposition","volume":"49","author":"Moller","year":"2011","journal-title":"Rhinology"},{"key":"R14-51-20240830","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1089\/jamp.2014.1180","article-title":"Nasal deposition of HFA-beclomethasone, aqueous fluticasone propionate and aqueous mometasone furoate in allergic rhinitis patients","volume":"28","author":"Leach","year":"2015","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"R15-51-20240830","doi-asserted-by":"crossref","first-page":"AB39","DOI":"10.1016\/j.jaci.2012.12.823","article-title":"Qnasl\u00ae non-aqueous nasal aerosol delivers softer sprays than aqueous Flonase\u00ae, Nasacort AQ\u00ae, and Nasonex\u00ae","volume":"131","author":"Ly","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"R16-51-20240830","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/alr.22025","article-title":"A validated model for the 22-item Sino-Nasal Outcome Test subdomain structure in chronic rhinosinusitis","volume":"7","author":"Feng","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"R17-51-20240830","first-page":"735","article-title":"Development, cultural adaptation, reliability and validity of Persian version of Sino-Nasal outcome test in chronic rhinosinusitis: A brief report","volume":"70","author":"Naghdi","year":"2013","journal-title":"Tehran Univ Med J"},{"key":"R18-51-20240830","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0194-5998(97)70005-6","article-title":"Staging for rhinosinusitis","volume":"117","author":"Lund","year":"1997","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R19-51-20240830","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2500\/aap.2011.32.3438","article-title":"Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis: A white paper","volume":"32","author":"Luskin","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"R20-51-20240830","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0091-6749(97)70160-X","article-title":"A comparison of triamcinolone acetonide nasal aerosol spray and fluticasone propionate aqueous solution spray in the treatment of spring allergic rhinitis","volume":"100","author":"Small","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"R21-51-20240830","first-page":"S11","article-title":"Patient preferences and satisfaction with prescribed nasal steroids for allergic rhinitis","volume":"22","author":"Kaliner","year":"2001","journal-title":"Allergy Asthma Proc"},{"key":"R22-51-20240830","first-page":"S1","article-title":"Introduction: Patient preference of inhaled nasal corticosteroids","volume":"22","author":"Storms","year":"2001","journal-title":"Allergy Asthma Proc"},{"key":"R23-51-20240830","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.2500\/aap.2010.31.3347","article-title":"Nasal allergies in the Latin American population: Results from the Allergies in Latin America survey","volume":"31","author":"Neffen","year":"2010","journal-title":"Allergy Asthma Proc"},{"key":"R24-51-20240830","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/pgmj.60.704.404","article-title":"A comparison of beclomethasone dipropionate aqueous nasal spray and beclomethasone dipropionate pressurized nasal spray in the management of seasonal rhinitis","volume":"60","author":"Dunn","year":"1984","journal-title":"Postgrad Med J"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_30_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:50:51Z","timestamp":1787755851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_30_20"}},"subtitle":["A Randomized Control Trial"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_30_20","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}